Skip to main content

Organon & Co.

OGN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001821825

In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.

Politicians who traded OGN

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
3
Filings
3
Politicians
3
Buys / sells
0 / 3
Estimated volume
$24.0K
Sum of range midpoints
Politicians who traded OGN
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Kevin Hern House · OK
10 / 1$8.00KAug 5, 2026Aug 12, 2026
Gary C. Peters Senate · MI
10 / 1$8.00KJul 10, 2025Nov 24, 2025
10 / 1$8.00KJun 28, 2021Jul 9, 2021

Trades

Reported trades in Organon & Co., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
OGNOrganon & Co.Sell (full)SelfJun 28, 2021Jul 9, 202111 days$1K-$15KFiling
Gary C. Peters Senate · MI
OGNOrganon & Co.Sell (full)SelfJul 10, 2025Nov 24, 2025137 daysLate$1K-$15KFiling
Kevin Hern House · OK
OGNOrganon & Co. Common StockSellJointAug 5, 2026Aug 12, 2026Amended5 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.